Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Jung Won Woo
Genexine, Inc.
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
95
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
GX-188E DNA Vaccine Plus Pembrolizumab as a 2nd Line Treatment for HPV 16- and/or 18-Positive, PD-L1 All-Comer Recurrent or Advanced Cervical Cancer: A Prospective, Multicenter, Single-Arm, Phase II Clinical Trial
Number of pages: 32
Posted: 02 Jan 2024
Myong Cheol Lim
,
Myong Cheol Lim
,
Youn Jin Choi
,
Soo-Young Hur
,
Yong-Man Kim
,
Jae Hong No
,
Byoung-Gie Kim
,
Chi Heum Cho
,
Sunghoon Kim
,
Dae Hoon Jeong
,
Jae-Kwan Lee
,
Ji Hyun Kim
,
Yoon-Jeong Choi
, Jung Won Woo,
Young Chul Sung
and
Jong Sup Park
Chinese Academy of Medical Sciences - Center for Gynecologic CancerNational Cancer Center, Korea - Center for Gynecologic Cancer, Catholic University of Korea, Catholic University of Korea, University of Ulsan - Asan Medical Center, Seoul National University - Seoul National University Bundang Hospital, Sungkyunkwan University - Samsung Medical Center, Keimyung University Dongsan Medical Center, Yonsei University - College of Medicine, Inje University, Korea University, Chinese Academy of Medical Sciences - Center for Gynecologic Cancer, Genexine, Inc., Genexine, Inc., Pohang University of Science and Technology (POSTECH) and Catholic University of Korea
Downloads
95
(720,278)
View PDF
Download
Abstract:
Feedback